We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
23/4/2022 15:45 | Dividend calendar Details of our dividend timetable by quarter. Dividend timetable for Q1 2022 Announcement date Wednesday 27 April 2022 Ex-dividend date* Thursday 19 May 2022 Record date Friday 20 May 2022 Last date for DRIP elections Thursday 16 June 2022 Payable Thursday 7 July 2022 BUY BEFORE EX DIVI DATE YOUR LAST BUY DATE TO GET DIVI Wednesday 18 May 2022 | waldron | |
23/4/2022 08:39 | Hi there if I invest before record day will I get my dividend ? Something about ex dividend date ? They are only one day apart so can I buy and sell in 3 days and get my dividend ? Sorry for asking just confused . Also is it worth buying on Monday before the Divi announcement next wed or will share price be expected to fall then ? Thank you | alibizzle | |
22/4/2022 09:46 | Hi Dud, some bad numbers out this morning and GBP hit which should benefit Big Pharma. I have little in the market at present, in some boring utilities etc. I am very bearish. In so far as GSK is concerned the split should give some short term gain and may (likely?) attract predators, particularity with a cheaper currency. I have closed my GSK positions for now. DYOR etc. | alphorn | |
22/4/2022 09:00 | Alphorn, Whilst making large gains dot/com, I did admit to losses. Eye off the ball, I lost £24K RTD (Retail Decisions). I was warned by a colleague but ignored, my mistake. Lesson learnt. GSK/AZN both dipping, should I stay or should I go? Mindset at the moment is take divvies in May and move on? Your thoughts always appreciated. cheers | dudishes | |
22/4/2022 08:36 | The weak pound good for U.K. dollar earners, who report in dollars, bigger dividends when converted into sterling. | netcurtains | |
21/4/2022 12:52 | GSK/CureVac second gen COVID-19 shot shows promise against Omicron in mouse study CureVac (NASDAQ:CVAC) shares are trading higher in the pre-market Thursday after the German biotech announced promising pre-clinical data for a second-generation bivalent COVID-19 vaccine candidate it jointly develops with GlaxoSmithKline (NYSE:GSK). In the study, the animals were immunized on day 0 and day 28 with a 0.5 µg dose of the monovalent second-generation vaccine candidate or with a 0.5 µg dose of the bivalent vaccine candidate combining two mRNAs encoding for the Beta and the Delta variant. According to the company, the experimental bivalent candidate “significantly reduced” the virus level of mice upon exposure to either variant on day 56. Notably, the bivalent vaccine candidate is found to have led to twofold higher virus neutralizing antibody levels against the Omicron variant compared to the levels seen against the Delta variant. In March, CureVac (CVAC) announced the dosing initiation in a Phase 1 trial for its GSK (GSK)-partnered second gen mRNA-based COVID-19 vaccine called CV2CoV. | geckotheglorious | |
20/4/2022 19:56 | Notice that the Dow Jones comment on the GSK/Unite pay dispute this evening provides a slightly different slant to the criticism by the Unite union mentioned in the LSE report in philanderer's post. It includes the following: According to the union, GlaxoSmithKline's offer for a 2.75% pay rise equals a pay cut for the workforce, given that the true rate of inflation stands at 9%. It hailed the offer as "derisory" and said the company now has 48 hours to make an improved offer, or the strike will be announced. In response, the company said it actually offered a 4% increase in addition to a 2% one-off award and an annual bonus, and that 2.75% referred to an opening offer it made months ago. | grahamburn | |
20/4/2022 14:27 | We'll know more in June 2022: Due to its size, the demerger qualifies as a Class 1 transaction under the UK Listing Rules and so requires the approval of GSK shareholders at a general meeting. A circular is expected to be sent to GSK shareholders in connection with approval of the proposed demerger and separation in June 2022, alongside publication of a prospectus in connection with the listing of Haleon. A shareholder vote for approval and subsequent demerger is expected in July 2022. Haleon shares are expected to attain a premium listing on the London Stock Exchange, with ADRs listed in the US. | tradermichael | |
20/4/2022 12:29 | Fwiw I've been in gsx since June 2000, always took divis as shares until last year and now take cash. Effective annual return of 9.4% pa valued at todays price | baddeal | |
20/4/2022 11:20 | I have been into GSK for about 20 years. I remember I paid over £19 for my first tranche. My break even is about £15.50. I sold 26% of my holding recently when they went back over £17. Like TM, I have always reinvested the generous divis. For the last 10 years (or so) GSK has been by far my largest holding. You could say I have been seduced by the divis. Not a good investment strategy - I know. I remember the time when GSK and AZN were close in value, and I considered buying some, but I thought GSK were better value!! | jonjoneil | |
20/4/2022 11:00 | Yes, andy! Good luck as well. | tradermichael | |
20/4/2022 10:56 | I've got an extensive list of losses, wouldn't know where to begin...however GSK is not one of them. Over the years, in and outs and divis, GSK has been the most profitable of them all. | andyadvfn1 | |
20/4/2022 10:55 | Yes, I have been buying GSK for over 10 years, where possible I have been using the price movements (troughs to buy and peaks to sell, and buying back on subsequent falls - there have been many of them!) and adding profits and other lump sums and re-investing all the dividends. | tradermichael | |
20/4/2022 10:45 | Thanks TM. Now it makes sense! :--) | jonjoneil | |
20/4/2022 10:28 | It's worth about 940 grand off the top of my head. | pierre oreilly | |
20/4/2022 10:21 | To you jj and PO: I added 1426 GSK shares to my holding of 49712 shares, for what its worth! My point is that even though the price is higher than its been for a LONG time, there are still buyers out here, prepared to invest well ahead of the 'split' .... ;0) | tradermichael | |
20/4/2022 10:20 | I have had no doubt about TM's holdings over time. Of more interest on ADVFN is that posters only seem to have gains. A very skewed population. ;) | alphorn | |
20/4/2022 10:15 | Someone on here once said they were on a horse racing site, and anyone wanting to say how much they'd won on the last race had to put a photo of the betting slip in the post, else the moderators deleted it. Would be great on here - for those who like to brag about their trades or winning investments (like me sometimes, but only the winning ones), then they should post the contract note. | pierre oreilly | |
20/4/2022 09:47 | Bought X shares @ 1755.6. Sorry, but without knowing the value of 'X', the post is pointless :--) | jonjoneil | |
20/4/2022 09:12 | IN @ 1755.6 ....;0) | tradermichael | |
19/4/2022 15:53 | You are saying the same thing - We need to be aware if they start announcing PI, PII and PIII trials like a tiddler! | alphorn | |
19/4/2022 15:20 | Looking for renewed interest for the split with CH figures next week. | tradermichael |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions